Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,001 | 3,559 | 17,323 | 1,879 | 2,723 |
| Cost of Goods | N/A | N/A | 691 | 367 | 329 |
| Gross Profit | 2,001 | 3,559 | 16,632 | 1,512 | 2,394 |
| Operating Expenses | 25,622 | 26,990 | 23,094 | 29,232 | 30,036 |
| Operating Income | -23,621 | -23,431 | -5,772 | -27,353 | -27,313 |
| Interest Expense | 16,284 | 5,177 | 13,678 | 1,088 | 1,691 |
| Other Income | 10,439 | 775 | -6,277 | 2,895 | 9,992 |
| Pre-tax Income | -29,466 | -27,833 | -25,727 | -25,546 | -19,012 |
| Income Tax | 258 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -29,724 | -27,833 | -25,812 | -25,548 | -19,012 |
| Net Income Discontinuous | 13,083 | -4,691 | -2,744 | -5,718 | -442 |
| Minority Interests | -4,934 | -2,450 | -1,744 | -2,798 | -506 |
| Net Income | $-11,707 | $-30,075 | $-26,814 | $-28,467 | $-18,948 |
| EPS Basic Total Ops | -0.20 | -0.58 | -0.58 | -0.63 | -0.42 |
| EPS Basic Continuous Ops | -0.53 | -0.54 | -0.56 | -0.56 | -0.42 |
| EPS Basic Discontinuous Ops | 0.24 | -0.09 | -0.06 | -0.13 | -0.01 |
| EPS Diluted Total Ops | -0.20 | -0.58 | -0.58 | -0.63 | -0.42 |
| EPS Diluted Continuous Ops | -0.53 | -0.54 | -0.56 | -0.56 | -0.42 |
| EPS Diluted Discontinuous Ops | 0.24 | -0.09 | -0.06 | -0.13 | -0.01 |
| EBITDA(a) | $-19,202 | $-18,975 | $-1,044 | $-23,047 | $-22,812 |